title: Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis.
abstract: Endoplasmic reticulum (ER) stress and apoptotic cell death play an important role in the pathogenesis and perpetuation of inflammatory bowel disease (IBD). We aimed to explore the potential of glutamine to reduce ER stress and apoptosis in a rat model of experimental IBD. Colitis was induced in male Wistar rats by intracolonic administration of 30 mg of 2,4,6-trinitrobenzene sulfonic acid (TNBS). Glutamine (25 mg/dL) was given by rectal route daily for 2 d or 7 d. Both oxidative stress (TBARS concentration and oxidised/reduced glutathione ratio) and ER stress markers (CHOP, BiP, calpain-1 and caspase-12 expression) increased significantly within 48 h of TNBS instillation, and glutamine attenuated the extent of the changes. Glutamine also inhibited the significant increases of ATF6, ATF4 and spliced XBP-1 mRNA levels induced by TNBS instillation. TNBS-colitis resulted in a significant increase in p53 and cytochrome c expression, and a reduced Bcl-xL expression and Bax/Bcl-2 ratio. These effects were significantly inhibited by glutamine. Treatment with the amino acid also resulted in significant decreases of caspase-9, caspase-8 and caspase-3 activities. Double immunofluorescence staining showed co-localization of CHOP and cleaved caspase-3 in colon sections. Phospho-JNK and PARP-1 expression was also significantly higher in TNBS-treated rats, and treatment with glutamine significantly decreased JNK phosphorylation and PARP-1 proteolysis. To directly address the effect of glutamine on ER stress and apoptosis in epithelial cells, the ER stress inducers brefeldin A and tunicamycin were added to Caco-2 cells that were treated with glutamine (5 mM and 10 mM). The significant enhancement in PERK, ATF6 phosphorylated IRE1, BiP and cleaved caspase-3 expression induced by brefeldin A and tunicamycin was partly prevented by glutamine. Data obtained indicated that modulation of ER stress signalling and anti-apoptotic effects contribute to protection by glutamine against damage in TNBS-induced colitis.
authors.affiliation: Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), León, Spain.
authors.forename: Irene
authors.initials: I
authors.lastname: Crespo
authors.forename: Beatriz
authors.initials: B
authors.lastname: San-Miguel
authors.forename: Carolina
authors.initials: C
authors.lastname: Prause
authors.forename: Norma
authors.initials: N
authors.lastname: Marroni
authors.forename: María J
authors.initials: MJ
authors.lastname: Cuevas
authors.forename: Javier
authors.initials: J
authors.lastname: González-Gallego
authors.forename: María J
authors.initials: MJ
authors.lastname: Tuñón
mesh_terms: D000818:Animals; D017209:Apoptosis; D020126:Brefeldin A / Q000494:pharmacology; D018938:Caco-2 Cells; D020169:Caspases / Q000378:metabolism; D045744:Cell Line, Tumor; D002470:Cell Survival; D003092:Colitis / Q000378:metabolism*; D004721:Endoplasmic Reticulum / Q000378:metabolism*; D005973:Glutamine / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D015212:Inflammatory Bowel Diseases / Q000378:metabolism; D008297:Male; D018384:Oxidative Stress; D010766:Phosphorylation; D051381:Rats; D017208:Rats, Wistar; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D051742:Transcription Factor CHOP / Q000378:metabolism; D014302:Trinitrobenzenesulfonic Acid / Q000494:pharmacology; D014415:Tunicamycin / Q000494:pharmacology
chemical_list: D017392:Thiobarbituric Acid Reactive Substances; D005973:Glutamine; D014415:Tunicamycin; D051742:Transcription Factor CHOP; D020126:Brefeldin A; D014302:Trinitrobenzenesulfonic Acid; D020169:Caspases